Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
| Status: | Withdrawn |
|---|---|
| Conditions: | Infectious Disease, Hospital |
| Therapuetic Areas: | Immunology / Infectious Diseases, Other |
| Healthy: | No |
| Age Range: | 19 - 90 |
| Updated: | 4/17/2018 |
| Start Date: | January 2009 |
| End Date: | January 2010 |
The purpose of this study is to determine if the use of autologous platelet gel (APG) on
sternal incision and conduit sites will improve wound healing and decrease the incidence of
infection in patients undergoing coronary artery bypass grafting surgery
sternal incision and conduit sites will improve wound healing and decrease the incidence of
infection in patients undergoing coronary artery bypass grafting surgery
Inclusion Criteria:
- Any patient who meets criteria and consents to undergo a CABG procedure involving
conduit sites and consents to this study.
Exclusion Criteria:
- Any patient, after inclusion, whom is later determined to have had on-going therapy
that could influence wound healing such as radiation or chemotherapy, extensive
steroid use, or accidental trauma such as burns, etc.
We found this trial at
1
site
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
Click here to add this to my saved trials
